Prasad Pathange, Ph.D.
Director, CMC Process Development & Commercialization, Bayer U.S.
Prasad Pathange, Ph.D. is listed as Director, CMC Process Development & Commercialization, Bayer U.S.. Prasad is scheduled to speak at BPI West 2027 on 18 March 2027.
Compiled from published conference agendas; not yet confirmed by Prasad. Is this you? Claim this profile.
About
Prasad Pathange is a Director at Bayer U.S, leading upstream and downstream process development. With 18+ years in commercial lifecycle management, he focuses on process optimization, validation, scale‑down qualification, deviation investigations, and COGs reduction. He leads cross‑functional teams advancing manufacturing simplification, PAT integration, technology adoption, and prelaunch process transfers to accelerate commercialization. Prasad holds an M.S. and Ph.D. in Bio‑Systems Engineering from Virginia Tech.
Upcoming
BPI West 2027 16 March 2027 – 18 March 2027
- Implementing a Lower-Cost Resin in a Licensed Process: A CMC Case Study Speaker · 18 March 2027
- Shared Panel Discussion: How can Bioprocess Engineering Reduce Manufacturing Costs? Speaker · 18 March 2027
Spoke alongside
People who have shared a session with Prasad at events on B2DB.
- Alois Jungbauer Professor, Dept. of Biotechnology · BOKU University (BOKU) 1 shared session
- Irina Ramos, Ph.D Senior Director · Johnson & Johnson Innovative Medicine 1 shared session